# Progyny, Inc.: insider transactions

PGNY · Nasdaq · CIK 1551306 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pgny.md) · [Financials](/companies/pgny/financials.md) · [Filings](/companies/pgny/filings.md) · [Insiders](/companies/pgny/insiders.md)

## All transactions: 2

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2020-05-20 | [Glaxosmithkline plc](/insiders/1131399.md) | 10% owner | Sale (S) | 4,000,000 | $25.75 | $103.0m | [Form 4](/filings/0001387131-20-005115.md) |
| 2019-10-29 | [Glaxosmithkline plc](/insiders/1131399.md) | 10% owner | Conversion (C) | 9,821,190 | not reported | not reported | [Form 4](/filings/0001387131-19-008140.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 17:30 ET. No prices; not investment advice.